The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells. (Molecular and cellular endocrinology, 2010)

(untitled) - Grozinsky-Glasberg, S; Rubinfeld, H; Nordenberg, Y; Gorshtein, A; Praiss, M; Kendler, E; Feinmesser, R; Grossman, AB; Shimon, I